IVX Health, a Brentwood, Tenn.-based provider of outpatient infusion centers, completed a $100 million Series F round from Great Hill Partners. Previous investors in the company include McKesson Ventures, Health Velocity Capital and Nueterra Capital. Mark Taber, a managing director at Great Hill Partners, will join IVX’s round.
Pager Inc., a New York-based virtual-care navigation and collaboration platform, raised $70 million in Series C equity and debt funding. Susquehanna Private Equity Investments led the round, which saw participation from an affiliate of Horizon Healthcare Services Inc. Silicon Valley Bank provided the debt portion. Health Catalyst Capital, Goodwater Capital, Lux Capital and New Enterprise Associates are also backers of Pager.
Nomad Health Inc., a New York-based digital marketplace for temporary healthcare jobs, snagged $63 million in new equity and debt financing. Adams Street Partners led the round, which included contributions from Icon Ventures, Polaris Partners, RRE Ventures, .406 Ventures, First Round Capital and Silicon Valley Bank. In addition to the investment, Nomad Health appointed Kim Howard as chief client officer and Jeff Simon as vice president of product.
Hexagon Bio Inc., a Menlo Park, Calif.-based developer of small-molecule medicines mined from microbial genomes, fetched a $61 million investment led by Nextech Invest. New investors SoftBank Vision Fund 2 and Casdin Capital also participated in the round, along with previous backers The Column Group, 8VC and Two Sigma Ventures.
858 Therapeutics, a San Diego-based startup developing small-molecule therapeutics for the treatment of cancer, emerged from stealth with $60 million in Series A funding. Versant Ventures led the round, which included participation from New Enterprise Associates, Cormorant Asset Management and Logos Capital.
Centivo, a Buffalo, N.Y.-based employer-sponsored health plan provider, picked up a $51 million investment. B Capital Group and Maverick Capital co-led the round, which included support from Bain Capital Ventures, Company Ventures, Define Ventures, F-Prime Capital, HarbourVest Partners, Ingleside Investors, Nassau Street Ventures and others.
Cytrellis Biosystems Inc., a Woburn, Mass.-based developer of dermatologic aesthetic devices for the removal of sagging skin due to aging, closed a $50 million Series C round led by D1 Capital Partners. Additional new investor Sands Capital also participated in the funding, along with existing backers ARCH Venture Partners and PFM Health Sciences.
Credence MedSystems Inc., a Menlo Park, Calif.-based developer of drug delivery systems, secured a $39.9 million investment from Novartis Pharma, Molex Ventures and others.
HumanCo, an Austin, Texas-based holding company dedicated to creating products focused on healthier living and sustainability, grabbed $35 million in bridge funding from investors including 8VC and JAZZ Venture Partners. Along with the investment, HumanCo acquired Against the Grain, a baker of grain-free and gluten-free products.
NOCD, a Chicago-based provider of a treatment for obsessive compulsive-disorder, nabbed $33 million in Series B funding. Lead investor F-Prime Capital was joined by Eight Roads Ventures, Kaiser Permanente Ventures, 7wireVentures, Health Enterprise Partners and Chicago Ventures in the round.
Tact.ai, a Sunnyvale, Calif.-based provider of customer engagement software to life science organizations, added $33 million in a new round of funding from dRx Capital, M12, Salesforce Ventures, Eli Lilly & Co. and McKesson Ventures.
Intenseye, a New York- and Istanbul-based employee health and safety software platform, collected a $25 million Series A investment. Insight Partners led the round, which included participation from Point Nine and Air Street Capital.
Vodori, a Chicago-based cloud software provider for life science companies, landed $7.5 million in Series A funding led by Baird Capital. Jim Pavlik, partner with Baird Capital's venture capital team, will join the board.
|